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In South American folk medicine members of the genus Myrciaria are used for the treatment of malaria, 
diarrhoea, asthma, inflammation and post-partum uterine cleansing. The aim of this work was to evaluate 
its antileishmanial properties (in vitro) of essential oil derived from leaves of Myrciaria plinioides D. 
Legrand, a plant species that is native in South of Brazil. The essential oil was obtained by hydro-distillation 
using fresh leaves of M. plinioides. The chemical composition of this essential oil (MPEO, M. plinioides 
essential oil) was determined by gas chromatography coupled to mass spectrometry (GC-MS). MPEO 
was assayed in vitro for antileishmanial properties against promastigotes of Leishmania amazonensis 
and Leishmania infantum, and for cytotoxicity against murine peritoneal macrophages. The MPEO 
comprised 66 components and was rich in oxygenated sesquiterpenes (82.66%) containing spathulenol 
(21.12%) as its major constituent. The MPEO was effective against L. amazonensis with IC50 value of 
14.16 ± 7.40 µg/mL, while against L. infantum the IC50 value was higher with 101.50 ± 5.78 µg/mL.  
The MPEO showed significant activity against L. amazonensis, and presented a selectivity index (SI) 
of 6.60. The results suggest that the essential oil from leaves of M. plinioides is a promising source for 
new antileishmanial agents against L. amazonensis.
Keywords: Antileishmanial activity. Myrciaria plinioides. Myrtaceae. Leishmania amazonensis. 
Leishmania infantum.
INTRODUCTION
Leishmaniasis, a parasitic infection caused by 
protozoa of the genus Leishmania, rates as one of the 
most pernicious of neglected tropical diseases. Some 
350 million people worldwide are at risk of contracting 
one of the forms of the disease, and around 2 million 
new cases occur annually, mainly within the poorest 
populations in developing countries. Various factors have 
contributed to the increase in the number of cases of the 
disease, especially the difficulties associated with vector 
control and the lack of a vaccine (Freitas-Junior et al., 
2012). Moreover, drugs such as meglumine antimoniate 
and pentamidine isethionate that are commonly employed 
in the treatment of leishmaniasis are of somewhat 
limited application because of issues relating to routes of 
administration, adherence to treatment, resistance, toxicity 
and/or teratogenicity (Buckner, Waters, Avery, 2012). 
Alternative therapies, including miltefosine and 
paromomycin, and new formulations of older medications 
such as amphotericin B, have been introduced but most 
are restricted in their use and none provide a satisfactory 
treatment of the disease (Freitas-Junior et al., 2012). 
In this context, medicinal plants that have been applied 
in traditional remedies often represent promising 
sources of lead compounds for the development of new 
drugs (Oliveira et al., 2011). Within the last few years, 
considerable research interest has focused on screening 
plant extracts as potential sources of drugs for the treatment 
of leishmaniasis (Vila-Nova et al., 2011; Cota et al., 2012; 
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Ramírez-Macías et al., 2012; Vila-Nova et al., 2012; 
Santos et al., 2013). 
Members of the family Myrtaceae are ubiquitous 
in Brazil, and the presence of around 1000 species in 
discrete biomes, principally the Atlantic forest, restinga 
and cerrado, suggests an ecological importance. Myrciaria 
is a genus of large shrubs and small trees belonging to the 
myrtle family, and various species are used in traditional 
medicine (Souza, Lorenzi, 2012).
The shrub Myrciaria plinioides D. Legrand, 
popularly known as camboim, cambuim or cambuí, is 
native to the state of Rio Grande do Sul in southern Brazil. 
Despite the medicinal potential of this species, very few 
reports are available concerning its pharmacological 
activities. For example, tea prepared from the leaves 
of Myrciaria tenella, popularly known as vassourinha, 
is employed in the Amazonian region as a post-partum 
uterine cleansing agent (Coelho-Ferreira, 2009), while 
the volatile oil obtained from leaves of this species is 
rich in α-pinene and β-pinene and exhibits antimicrobial 
activity against Enterobacter spp. and Shigella flexneri 
(Schneider et al., 2008). Additionally, the leaves and 
trunk bark of M. cauliflora (popular name jabuticaba) are 
used to treat diarrhoea, asthma, and throat inflammation 
(Albuquerque et al., 2007), while ethanolic extracts of 
the leaves exhibit inhibitory action against Candida 
and Streptococcus cultures derived from dental plaque 
(Carvalho et al., 2009; Diniz et al., 2010). Of particular 
interest is the report (Ruiz et al., 2011) that the edible fruits 
of M. dubia are employed by Indigenous and Mestizo 
populations living on the banks of the Nanay river in 
the Loreto region of Peru as a traditional remedy for the 
treatment of malaria, which is also a neglected protozoan 
infection.
In consideration of the above, we have assessed 
the in vitro activities of essential oil of M. plinioides 
against Leishmania infantum (syn. L. chagasi), which 
is the causal agent of visceral leishmaniasis, and against 
L. amazonensis, a species that has been associated with 
various clinical forms of the disease including cutaneous, 
mucosa, diffuse cutaneous and visceral leishmaniasis 
(Leon et al., 1990). In addition, we have determined the 
composition of the essential oil derived from this native 
Brazilian species. 
MATERIAL AND METHODS
Plant material 
Leaves of Myrciaria plinioides D. Legrand were 
collected in Lajeado, RS, Brazil during July 2012. The 
plants were authenticated by the botanist Dr. Elisete 
Maria de Freitas (Centro Universitário UNIVATES) and 
a voucher specimen was deposited at the Herbário do Vale 
do Taquari, Museu de Ciências Naturais UNIVATES under 
the registration number HVAT1066.
Preparation of essential oil
Fresh leaves (200 g) of M. plinioides were subjected 
to hydro-distillation for 3.5 h in a Clevenger-type 
apparatus. The essential oil (MPEO) was dried over 
anhydrous sodium sulphate, transferred to amber glass 
bottles and stored at −20 °C, until required for chemical 
analysis and bioassay. 
Chemical analysis of the essential oil
Samples  o f  MPEO were  ana lysed  by  gas 
chromatography coupled to mass spectrometry 
(GC-MS) at the Instrumental Analysis Laboratory, 
Food Processing Development Centre -  FPDC, 
Univates. Analyses were performed on a Shimadzu 
GC2010 Plus system, comprising a model AOC-
5000 Plus auto injector and a model QP2110 Ultra 
mass detector, using a Restek Rtx®-5MS fused silica 
capillary column (30 m x 0.25 mm i.d.; 0.25 μm film 
thickness). The chromatographic conditions were: 
carrier gas - helium at a flow rate of 1.00 mL/min; 
oven temperature - initially at 50 °C and increased at 
4 °C/min to 290 °C; injector temperature - 240 °C; 
injection mode - split with 1:20 ratio and 3 mL/min 
purge; MS interface temperature - 280 °C; ion source 
temperature - 260 °C; ionisation energy - 70 eV. Oil 
samples (15 mg) were dissolved in 1.5 mL of purified 
ethyl acetate and aliquots in the order of 1 μL were 
injected for analysis. GC analyses with flame ionisation 
detection (FID) were carried out using an Agilent J & W 
HP-5 MS column (30 m x 0.25 mm i.d.; 0.25 µm film 
thickness) with helium as carrier gas, an FID temperature 
of 260 °C and the oven temperature program as described 
for the GC-MS procedure. 
Separated components were identified initially 
from their Kováts retention indices (RI), determined by 
reference to a series of n-alkanes, and their identities 
confirmed by comparison of mass spectral data with those 
obtained using pure standards together with values quoted 
in the literature (Adams, 2009) and those stored in the 
Wiley 8 and NIST11 spectral libraries of the analytical 
system. The relative compositions of the oils were 
calculated from the peak areas (uncorrected for specific 
response factors) of the separated components.
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Cultivation of Leishmania promastigotes
Promastigotes of L. amazonensis MHOM/BR/77/
LTB0016 were grown at 26 ºC in Schneider’s Drosophila 
medium (Sigma-Aldrich) supplemented with 10% (v/v) 
heat-inactivated fetal calf serum (FCS) and adjusted to 
pH 7.2. Promastigotes of L. infantum MCAN/BR/97/P142 
were cultivated at the same temperature and pH, but in this 
case the medium was supplemented with 20% (v/v) FCS, 
2% (v/v) human urine, 100 μg/mL streptomycin and 100 
U/mL penicillin. Promastigotes were harvested on day 4, 
when the percentage of infective metacyclic forms was 
found to be high, and counted in a Neubauer chamber. 
Parasite suspensions were adjusted to a concentration 
of 1x107 promastigotes/mL using the supernatant of the 
respective culture as diluent. 
Determination of antileishmanial activity in vitro
Appropriate amounts of MPEO or pentamidine 
isethionate (as reference drug) (Sideron®) were dissolved 
in aqueous dimethyl sulphoxide (DMSO; 10 mg/mL) to 
yield solutions containing analytes in the concentration 
range of 0.156 to 80 µg/mL. The level of DMSO in each 
assay solution was below 1.4%, which is the highest 
concentration that is not hazardous to the parasites. 
Suspensions of late log phase promastigotes 
suspended in Schneider’s Drosophila medium were 
seeded in Corning™ 96-well flat bottom tissue culture 
tested plates (1×107 promastigotes/200 μL/well). Aliquots 
of freshly prepared MPEO and pentamidine were added 
to the wells and the plates were incubated for 24 h at 
26 °C. Promastigote viability was evaluated using a 
modified version of the dye-reduction assay employing 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) (Dutta et al., 2005). Briefly, MTT reagent 
was added to each well and incubation was continued in 
the dark for an additional 4 h. After this time, an 80 µL 
aliquot of DMSO was added to each well and the optical 
density of the assay solution was determined at 570 nm 
using a BioTek μQuant™ microplate spectrophotometer. 
The specific absorbance associated with the formazan so-
produced was determined by subtracting the background 
absorbance from the total absorbance, and the mean 
percentage viability was calculated from:
Values for IC50, i.e. the concentration that inhibited 
parasite growth by 50%, were determined. 
Assessment of cytotoxicity 
Peritoneal macrophages from BALB/c mice were 
obtained by using the lavage technique, counted in a 
Neubauer chamber and adjusted to a concentration 
of 2 x106 cells/mL. Macrophages were transferred 
to Corning 96-well flat bottom tissue culture tested 
plates and incubated for 24 h at 37 ºC under a 5% CO2 
atmosphere. Freshly prepared solutions, in aqueous 
DMSO, containing MPOE or pentamidine isethionate 
at concentrations range 0.156 to 80 µg/mL were then 
added to the wells. Macrophage viability was evaluated 
using a modified version of the dye-reduction assay 
employing MTT. In order to assess macrophage viability, 
22 μL of MTT solution (5 mg/mL) was added to each 
well and the plates were incubated for an additional 2 h. 
After this time, an 80 µL aliquot of DMSO was added to 
each well and the optical density of the assay solution 
was determined at 540 nm using a BioTek μQuant™ 
microplate spectrophotometer. This study was approved 
for The Animal Ethics Committee of the Institute Oswaldo 
Cruz/IOC - FIOCRUZ (license number L-026/2015).
Statistical analysis
Assays were carried out in three independent 
experiments and each was performed in triplicate. 
Values of  IC50 and CC50 were determined by logarithmic 
regression analysis using GraphPrism 5 software. Values 
for in vitro antileishmanial activity and in vitro cytotoxicity 
were expressed as mean ± standard deviation. The 
significant differences between samples were evaluated by 
analysis of variance (ANOVA) and the Tukey test using 
BioEstat 5.0 software with the alpha level set at 0.05. 
RESULTS AND DISCUSSION
Analysis of the essential oil from fresh leaves of 
M. plinioides
The yield of essential oil obtained from fresh leaves 
of M. plinioides was 0.05% (w/w). According to the GC 
analyses, the oil comprised 66 components (Table I) 
and was particularly rich in oxygenated sesquiterpenes 
(82.66%) and sesquiterpene hydrocarbons (11.05%). 
The principal volatile components of the oil were the 
sesquiterpenes spathulenol (21.12%), caryophyllene 
oxide (15.20%), α-isolongifolan-7-ol (9.84%), mustakone 
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(5.60%), α-cadinol (5.40%), cis-isolongifolanone (3.38%) 
and α-copaene (3.27%).
Members of the family Myrtaceae are commonly 
rich in essential oils, many of which possess biological 
activity (Tietbohl et al., 2012; Borges, Conceição, Silveira, 
2014). In the case of M. floribunda, popularly known as 
camboin amarelo, monoterpenes predominated in the oils 
derived from leaves and flowers, with 1,8-cineole as the 
major component accounting for 38.4% of the leaf oil and 
22.8% of the flower oil (Tietbohl et al., 2012). In contrast, 
the stem oil contained mainly sesquiterpenes, of which 
(2E,6E)-farnesyl acetate represented the major component 
accounting for 19.9% of the oil. 
Oxygenated sesquiterpenes have been identified 
as major constituents of leaf oils from a number of 
Myrciaria species (Apel et al., 2006). Thus, the oil of 
M. cauliflora, similar to that of M. plinioides, contained 
mainly spathulenol (27.2%) and caryophyllene oxide 
(21.6%), while β-caryophyllene, caryophyllene oxide and 
spathulenol predominated in the essential oil of M. edulis. 
Conversely, the major components of M. trunciflora leaf 
oil were globulol, bicyclogermacrene and γ-muurolene, 
while the essential oil of M. cordifolia was rich in 
α-bisabolol oxide A, α-bisabolol oxide B, α-bisabolol 
and β-caryophyllene. The oxygenated sesquiterpenes 
spathulenol and caryophyllene oxide have been identified 
as major constituents of the essential oils of other 
members of the Myrtaceae, including Eugenia brasiliensis 
(Magina et al., 2009), E. calycina (Sousa et al., 2015), 
Eucalyptus camaldulensis (Verdeguer et al., 2009) and 
Callistemon citrinus (Petronilho et al., 2013).
In vitro antileishmanial activity and cytotoxicity 
of the essential oil from fresh leaves of 
M. plinioides
The essential oil derived from leaves of M. plinioides 
was effective against L. amazonensis promastigotes (Table 
II) and presented IC50 value of 14.16 ± 7.40 µg/mL, while 
the standard drug pentamidine isethionate presented 
IC50 value of 23.22 ± 9.04 µg/mL. However, activity 
against L. infantum promastigotes were less pronounced, 
presented an IC50 value of 101.50 ± 5.78 µg/mL (Table II).
American tegumentary leishmaniasis (ATL) affects 
populations in various regions of the world, including an 
area extending from southern USA to northern Argentina, 
with the exception of Chile and Uruguay. The disease can 
present with diverse clinical forms described as cutaneous, 
diffuse cutaneous or mucocutaneous. Moreover, ATL can 
cause injury way beyond its deforming effects, thereby 
raising issues concerning possible psychological damage 
and, consequently, social and economic losses (Amato 
Neto et al., 2008; Garcia et al., 2011). 
Antileishmanial activity has been demonstrated for 
essential oils from a number of plant species including 
Lippia origanoides (Escobar et al., 2010), L. sidoides 
(Medeiros et al., 2011; Farias-Junior et al., 2012) and 
Lantana camara (Machado et al., 2012). In the case of 
M. plinioides, it is likely that the antileishmanial activity 
of the leaf oil is associated with the presence of the 
sesquiterpenes spathulenol and caryophyllene oxide, 
which represent 36.32% of the total components. 
In this context, various studies have demonstrated 
that terpenes can cause alterations in the mitochondrial 
membrane potential, modification of the redox index, 
inhibition of cellular isoprenoid biosynthesis and changes in 
the plasma membrane (Santos et al., 2008; Rodrigues et al., 
2013; Monzote et al., 2014). According to Oliveira et al. 
(2014), the essential oil of Bocageopsis multiflora is also 
rich in spathulenol and exhibits in vitro antileishmanial 
activity against promastigotes of Leishmania amazonensis. 
Additionally, spathulenol and caryophyllene oxide have 
been identified as the principle components of the essential 
oil of Piper angustifolium (Bosquiroli et al., 2015), which 
also exhibits significant in vitro antileishmanial activity 
against L. infantum amastigotes. 
Monzote et al. (2014) carried out a comparative 
study of the essential oil of Chenopodium ambrosioides 
and its major constituents, namely ascaridole, carvacrol 
and caryophyllene oxide, and found that the natural 
mixture of the oil was potentially more active than the 
isolated components. Caryophyllene oxide, for example, 
exhibited non-specific activity and presented similar 
IC50 values against L. amazonensis and macrophages. 
Santin et al. (2009) reported an analogous situation for 
the essential oil of Cymbopogon citratus in which the 
principal constituent, citral, exhibited greater toxicity 
than the natural oil mixture. These results demonstrate 
the importance of complementary studies to determine 
whether the leishmanicidal activity against Leishmania 
promastigotes and cytotoxicity observed for M. plinioides 
is related to a specific component or mixture thereof.
 Pentamidine isethionate and other drugs used 
in the treatment of leishmaniasis are toxic and their 
application is limited owing to issues associated with high 
cost, acquired resistance, routes of administration and 
difficulties of adherence to treatment (Bucknerm Waters, 
Avery, 2012). The MPEO showed significant activity 
against L. amazonensis, and presented selectivity index 
(SI) of 6.60 (Table II). The activity against L. infantum 
promastigotas form of sample was less significant, besides 
that the SI data demonstrated considerable toxicity. 
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TABLE I - Composition of the essential oil from fresh leaves of M. plinioides
Compound RI
EXP
a RI
LIT
b
Relative 
composition 
(%)
NIc 1049 - 0.05
α-Terpineol 1194 1189 0.11
α-Ylangene 1373 1375 0.08
α-Copaene 1378 1376 3.27
β-Bourbonene 1386 1388 1.24
β-Elemene 1394 1391 0.26
β-Ylangene 1421 1421 0.09
β-Copaene 1431 1432 0.10
Aromadendrene 1440 1441 0.17
α-Humulene 1455 1455 0.08
allo-Aromadendrene 1462 1460 0.83
γ-Muurolene 1479 1480 0.67
cis-Eudesma-6,11-diene 1487 1490 0.11
trans-Muurola-4(14),5-diene 1496 1494 0.10
α-Muurolene 1503 1500 0.31
δ-Amorphene 1522 1512 0.55
trans-Calamenene 1535 1529 0.15
(E)-γ-Bisabolene 1554 1531 0.06
β-Vetivenene 1559 1533 0.84
Silphiperfol-5-en-3-ol B 1575 1535 1.53
Selina-3,7(11)-diene 1595 1546 0.65
1-nor-Bourbonanone 1601 1563 0.14
Spathulenol 1606 1578 21.12
Caryophyllene oxide 1610 1583 15.20
β-Copaen-4-α-ol 1613 1591 1.25
Khusimone 1617 1604 2.61
Curzerenone 1619 1606 1.22
β-Atlantol 1623 1608 0.43
cis-Isolongifolanone 1626 1613 3.38
Isolongifolan-7-α-ol 1631 1619 9.84
Junenol 1637 1619 0.82
2,(7Z)-Bisaboladien-4-ol 1642 1619 0.99
1,10-Di-epi-cubenol 1646 1619 2.13
trans-Isolongifolanone 1649 1626 0.24
β-Cedren-9-one 1652 1631 0.33
epi- α-Muurolol 1657 1642 2.65
α-Muurolol 1661 1646 1.54
Compound RI
EXP
a RI
LIT
b
Relative 
composition 
(%)
Vulgarone B 1663 1651 0.70
α-Cadinol 1667 1654 5.40
Selin-11-en-4-α-ol 1669 1659 0.63
cis-Calamenen-10-ol 1670 1661 0.26
14-Hydroxy-(Z)-caryophyllene 1673 1667 0.24
trans-Calamenen-10-ol 1677 1669 0.19
14-Hydroxy-9-epi-(E)-
caryophyllene
1679 1669 0.22
Cadalene 1682 1676 1.49
Mustakone 1685 1677 5.60
Khusinol 1690 1680 1.60
5-neo-Cedranol 1695 1685 0.36
Germacra-4(15), 5, 
10(14)-trien-1- α-ol
1702 1686 0.19
10-nor-Calamenen-10-one 1704 1702 0.45
Mayurone 1707 1704 0.43
E-Apritone 1711 1708 0.24
Longifolol 1716 1714 0.14
E-Nerolidyl acetate 1720 1717 1.70
iso-Longifolol 1728 1729 0.60
Vetiselinenol 1730 1731 0.10
Eremophilone 1735 1736 0.78
E-β-Santalol 1741 1739 0.41
8-α-11-Elemodiol 1748 1747 0.33
NI 1751 - 0.15
α-Bisabolol oxide A 1753 1749 0.45
β-Acoradienol 1767 1763 0.64
β-Costol 1772 1767 0.69
Khusinol acetate 1820 1823 0.18
NI 1839 - 0.43
8S,13-Cedranediol 1904 1897 0.22
Total constituents identified 99.37
Oxygenated monoterpenes 0.11
Sesquiterpene hydrocarbons 11.05
Oxygenated sesquiterpenes 82.66
a Experimental retention Index. b Literature retention Index 
(Adams, 2007). c Not identified.
The results obtained in this study reveal that the 
MPEO is promising as a source for new antileishmanial 
agents against L. amazonensis. However, more studies 
are necessary in order to determine the constituents 
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responsible for the antileishmanial activity and the 
mechanism of action involved. It stands out that the assay 
against promastigote forms is a preliminary screening to 
identify possible novel antileishmanial compounds, as it is 
a low cost and easy to handle method like in amastigotes 
(Siqueira-Neto et al., 2010). Even so, it is essential to 
evaluate the activity of MPEO against amastigote forms. 
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